Skip to content
SEARCH
Tech
Application Software
Communications
Computer Hardware
Online Media
Semiconductors
Consumer
Autos
Beverages
Consumer Packaged Goods
Entertainment
Manufacturing
Restaurants
Retail
Travel & Leisure
Financial
Asset Management
Banks
Brokers & Exchanges
Credit Services
Insurance
Politics
Trump
US Budget
Health
Healthcare
Biotechnology
Drug Manufacturers
Pharmaceutical
Basic Materials
Agriculture
Metals & Mining
Cobalt
Zinc
Gold
Silver
Lithium
Uranium
Copper
Energy
Oil & Gas
Alternative Energy
Biofuels
Hydro
Solar
Industrials
Aerospace and Defense
Airlines
Business Services
Consulting and Outsourcing
Farm & Construction Machinery
Industrial Products
Transportation & Logistics
Search
SEARCH FOR AN ARTICLE
Search
Search
Tech
Application Software
Communications
Computer Hardware
Online Media
Semiconductors
Consumer
Autos
Beverages
Consumer Packaged Goods
Entertainment
Manufacturing
Restaurants
Retail
Travel & Leisure
Financial
Asset Management
Banks
Brokers & Exchanges
Credit Services
Insurance
Politics
Trump
US Budget
Health
Healthcare
Biotechnology
Drug Manufacturers
Pharmaceutical
Basic Materials
Agriculture
Metals & Mining
Cobalt
Zinc
Gold
Silver
Lithium
Uranium
Copper
Energy
Oil & Gas
Alternative Energy
Biofuels
Hydro
Solar
Industrials
Aerospace and Defense
Airlines
Business Services
Consulting and Outsourcing
Farm & Construction Machinery
Industrial Products
Transportation & Logistics
SEARCH
Home
NASDAQ:BIIB
NASDAQ:BIIB
Drug Manufacturers
BIIB Stock Skyrockets as Investors Bet on Alzheimer’s Candidate
October 22, 2019
Health
Biogen Alzheimer’s Drug Trial Sees Positive Results, Shares Soar 20%
July 6, 2018
Health
After Reporting Q2 Profit and Revenue Beats, Biogen’s Shares Climbed 5.8%
July 25, 2017
Health
Brief: Alexion’s Stock Rises over 2% After Announcement of Hiring Biogen’s CFO
June 13, 2017
LATEST NEWS